This inventor holds 1 USPTO granted patent. Top assignee: Kong Kook Pharmaceutical Co., Ltd.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Innovations of San Beom Kim in Sustained Release Microparticles
Introduction
San Beom Kim is an accomplished inventor based in Kunsan, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release microparticles. His innovative approach has the potential to enhance therapeutic effects for various medical applications.
Latest Patents
San Beom Kim holds a patent for a "Sustained release microparticle and method for preparing the same." This patent discloses a method for preparing sustained release microparticles that release a physiologically active substance over extended periods. The process involves a multi-emulsion technique where a drug of interest is dissolved or dispersed in at least two oils, each containing a biodegradable polymer. The primary oil phases are then dispersed in an aqueous phase, leading to the formation of microparticles after the removal of organic solvents. This method allows for the continuous release of drugs, such as luteinizing hormone-releasing hormones, improving their therapeutic effects.
Career Highlights
San Beom Kim is associated with Kong Kook Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical innovations. His work focuses on developing advanced drug delivery systems that can significantly impact patient care and treatment outcomes.
Collaborations
Throughout his career, San Beom Kim has collaborated with notable colleagues, including Mork Soon Park and Dong Seon Kim. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical sector.
Conclusion
San Beom Kim's contributions to the field of sustained release microparticles exemplify the importance of innovation in pharmaceuticals. His work not only advances drug delivery methods but also enhances therapeutic efficacy for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile